期刊文献+

雷莫司琼和托烷司琼预防口腔颌面外科术后恶心、呕吐的疗效观察

Clinical observation of ramosetron and tropisetron in prevention postoperative nausea and vomiting after oral and maxillofacial surgery
下载PDF
导出
摘要 目的:比较雷莫司琼和托烷司琼预防口腔颌面外科术后恶心、呕吐的效果。方法:选择120例ASAⅠ~Ⅱ级择期行口腔颌面外科手术的患者,随机分为3组,在麻醉诱导前静脉注射雷莫司琼(R组,n=40)0.3mg、托烷司琼(T组,n=40)5mg、生理盐水(对照组,C组,n=40)5mL。观察术后24h内恶心、呕吐的发生情况,采用SPSS 11.0软件包对数据进行χ2检验。结果:术后24h内,恶心、呕吐的发生率R组和T组显著低于C组,差异有统计学意义(P<0.05),R组和T组比较差异无统计学意义(P>0.05)。结论:雷莫司琼和托烷司琼均可显著减少术后恶心、呕吐的发生率,两者疗效相当。 PURPOSE: To compare the preventive of ramosetron and tropisetron on postoperative nausea and vomiting after oral and maxillofacial surgery.METHODS: One hundred and twenty ASA Ⅰ-Ⅱgrade patients undergoing selective oral and maxillofacial surgery were randomly divided into 3 groups.0.3mg ramosetron(group R,n=40),5mg tropisetron(group T,n=40) and 5mL normal saline(control group,group C,n=40) were intravenously given to the patients respectively at the begin of general anesthesia.The patients were observed within 24h after operation for nausea and vomiting.The percentage of occurrence was compared with SPSS11.0 software package for χ2 test.RESULTS: After 24 hours,the incidence of nausea and vomiting in group R and group T was significantly lower than group C(P0.05),but no difference existed between group R and group T(P0.05).CONCLUSION: Ramosetron and tropisetron can significantly reduce the incidence of postoperative nausea and vomiting,and there is no difference in prevention of nausea and vomiting between the two drugs.
作者 蒋超 徐辉
出处 《中国口腔颌面外科杂志》 CAS 2011年第5期405-407,共3页 China Journal of Oral and Maxillofacial Surgery
关键词 恶心 呕吐 口腔颌面外科手术 雷莫司琼 托烷司琼 Nausea Vomiting Oral and maxillofacial surgery Ramosetron Tropisetron
  • 相关文献

参考文献15

二级参考文献72

  • 1严常开,曾繁典.甲氧氯普胺与恩丹西酮对化疗或术后恶心呕吐的疗效和安全性荟萃分析[J].中华消化杂志,2004,24(9):544-548. 被引量:10
  • 2胡国昌.恶心和呕吐的生理学[J].国外医学(麻醉学与复苏分册),1995,16(3):154-158. 被引量:128
  • 3杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 4徐建国.手术后恶心呕吐的防治[J].临床麻醉学杂志,2006,22(7):556-558. 被引量:147
  • 5沙济民.硬膜外腔曲马多注射术后止痛42例临床报告[J].新药临床动态,1991,1:47-47.
  • 6Shi Y, He X, Yang S, et al. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects:a prospective randomized controlled study. Chemotherapy, 2007,53: 44-50.
  • 7Charbit B, Albaladejo P, Funck-Brentano C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology, 2005,102 : 1094 -1100.
  • 8Gan TJ, Coop A, Philip BK. A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Anesth Analg, 2005,101 : 1323-1329.
  • 9Nuttall GA, Eckerman KM, Jacob KA, et al. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population? Anesthesiology, 2007,107 : 531-536.
  • 10Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg, 2003,97 : 62-71.

共引文献185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部